Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Case Report: Metoprolol-Induced Arthralgia

Case Report: Metoprolol-Induced Arthralgia

Saba Ziaee, MD, & Zineb Aouhab, MD  |  March 17, 2018

Various drugs are known to cause musculoskeletal symptoms, such as arthralgias, myalgias, drug-induced lupus and serum sickness.1 In the rheumatology world, the most commonly recognized drugs that can cause musculoskeletal symptoms are hydralazine, minocycline, fluoroquinolones and, recently, the dipeptidyl peptidase 4 (DPP-4) inhibitor class of medications. Although beta blockers also have a noted side effect…

Filed under:ConditionsSoft Tissue Pain Tagged with:arthralgiasbeta blockersmetoprolol

ACR Members Begin Work on CMS Committees

Carol Patton  |  March 16, 2018

TEP In February, Lisa Gale Suter, MD, joined the Technical Expert Panel (TEP) for the Centers for Medicare & Medicaid Services (CMS) Quality Measure Development Plan, supporting the transition to the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs). She was nominated to serve in this role by the ACR. The panel comprises…

Filed under:Professional Topics Tagged with:CMS committeesDouglas GrahamKent “Kwas” HustonLisa Gale SuterMedicare Evidence Development & Coverage Advisory Committee (MEDCAC)Technical Expert Panel (TEP)

Connect Rheumatology: A Conversation with Paul Sufka, MD, ACR Committee on Marketing & Communications Member

Carina Stanton  |  March 15, 2018

The field of rheumatology is advancing fast—alongside communication technologies that generate a massive amount of information. Paul Sufka, MD, a rheumatologist with HealthPartners in St. Paul, Minn., is interested in the ways social media can help him and other rheumatologists stay connected and keep abreast of practice information. “One thing I see people doing too…

Filed under:Profiles Tagged with:ACR Committee on Marketing & CommunicationsPaul Sufka MD

How to Attract Medical Students & Rheumatology Candidates

Karen Appold  |  March 12, 2018

As the shortage of rheumatologists is expected to worsen, practices and fellowship programs are asking how to attract top talent. Here are tips for how individuals can raise rheumatology’s profile and reach out to med students and new rheumatologists…

Filed under:Practice SupportWorkforce Tagged with:candidateemployeesFellowsmedical studentsmedical workforcepractice managment

Back to the Future: Spotlight on ACR Past President Dr. Herbert Kaplan

Aileen Lorenzo Pangan, MD  |  March 7, 2018

We are sad to report that Dr. Kaplan passed away on Saturday, June 23. We are reposting this story now to celebrate his life.

Filed under:From the CollegeProfiles Tagged with:KaplanProfiles

Opioids No Better Than NSAIDs for Chronic Back or Arthritis Pain

Lisa Rapaport  |  March 7, 2018

(Reuters Health)—Acetaminophen, ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) are better than opioids at easing the intensity of chronic pain in the back, knees or hips, a U.S. experiment suggests. And opioids are no better than these other drugs at reducing how much pain interferes with daily activities, such as walking, working, sleeping or enjoying…

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:Chronic painhiphip painKnee Osteoarthritis (OA)Nonsteroidal anti-inflammatory drugs (NSAIDs)NSAIDsOpioidsosteoarthritis (OA)PainPain Management

Support Your Young Scientists

Arthritis Care & Research  |  March 5, 2018

As the demand for rheumatology services increases, many rheumatologists struggle to maintain an academic research career. The absence of mentoring is often reported as a barrier to a career in research. To address this concern, researchers assessed the current state or mentorship in adult rheumatology, identifying what facilitates a successful mentor-mentee relationship for early career investigators to develop the framework for an interinstitutional mentoring program…

Filed under:Education & Training

Synovial Analysis Identifies Distinct Rheumatoid Arthritis Subtypes

Will Boggs MD  |  March 2, 2018

NEW YORK (Reuters Health)—Synovial gene expression and histology can be used to divide rheumatoid arthritis (RA) into high, low, and mixed inflammatory subtypes, according to results from the Accelerating Medicine Partnership: RA/SLE Network. “The actionable implication of these findings is that it may be worth considering synovial biopsies in patients who are not responding to…

Filed under:Rheumatoid Arthritis Tagged with:Accelerating Medicine Partnership: RA/SLE NetworkDana E. Orangeimmune suppressionRheumatoid Arthritis (RA)rheumatoid arthritis subtypessynovial analysissynovial biopsiessynovial gene expression

Biosimilar Bill Prompts Formation of Nebraska Rheumatology Society

Kelly Tyrrell  |  March 1, 2018

Last year, Nebraska rheumatologist Marcus Snow, MD, learned a biosimilar bill was up for debate in his state legislature, yet “I had no knowledge of it,” he says. Forming the Society The bill “was something that caught my eye, and I thought there should be a mechanism in place to allow us to disseminate information…

Filed under:Profiles Tagged with:Marcus SnowNebraska Rheumatology Societystate society

Advocacy Team Celebrates Healthcare Fixes, Prepares to Face New Threats

Angus Worthing, MD, FACP, FACR  |  March 1, 2018

Greetings, Advocates! Great news for the rheumatology community came on Feb. 9, when the Bipartisan Budget Act of 2018 was enacted. It contains several critical healthcare fixes pertinent to rheumatology. First, after hundreds of emails, meetings, letters to the editor, an op-ed, and a forceful 109-member coalition (led by the ACR and including many state…

Filed under:Legislation & Advocacy Tagged with:ACR advocacyACR Government Affairs CommitteeAngus WorthingBipartisan Budget ActD.C. updateGAChealthcare fixeshigh drug costsPart B drug costs

  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 332
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences